Review




Structured Review

Jackson Laboratory c57bl 6j nrf2
Expression analysis of BVRA missense mutants G17A and E97A <t>in</t> <t>C57BL/6J</t> mice (A) RT-qPCR analysis of Blvra mRNA expression in spleen, kidney, and liver from Blvra WT , Blvra −/− and Blvra G17A mice. Data are expressed as Blvra / Rplp0 (2 −ΔCt ) and presented as individual data points with bar graphs showing mean ± SD. n = 3 mice per genotype. (B) Western blot analysis of BVRA protein expression in spleen, kidney, and liver. Representative blots show BVRA (33 kDa) and β-actin (42 kDa) loading control. Quantification of BVRA protein levels normalized to β-actin is shown below each blot as individual data points with bar graphs showing mean ± SD. n = 3–5 per genotype. (C) RT-qPCR analysis of Blvra mRNA expression in spleen, kidney and liver tissues from Blvra WT , Blvra −/− , and Blvra E97A mice. Data are expressed as Blvra / Rplp0 (2 −ΔCt ) and presented as individual data points with bar graphs showing mean ± SD. n = 3 per genotype. (D) Western blot analysis of BVRA protein expression in spleen, kidney, and liver tissue. Representative blots and quantification of BVRA protein levels normalized to β-actin below each blot, shown as individual data points with bar graphs showing mean ± SD. n = 3–6 mice per genotype. Statistical comparisons were performed using one-way ANOVA with Tukey’s post hoc test. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001; NS, not significant.
C57bl 6j Nrf2, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nrf2/6j+c57bl+nrf2/pmc13200048-35-0-4
Average 86 stars, based on 1 article reviews
c57bl 6j nrf2 - by Bioz Stars, 2026-11
86/100 stars

Images

1) Product Images from "Hypomorphic biliverdin reductase a mutations define bilirubin anti-malarial threshold"

Article Title: Hypomorphic biliverdin reductase a mutations define bilirubin anti-malarial threshold

Journal: iScience

doi: 10.1016/j.isci.2026.115958

Expression analysis of BVRA missense mutants G17A and E97A in C57BL/6J mice (A) RT-qPCR analysis of Blvra mRNA expression in spleen, kidney, and liver from Blvra WT , Blvra −/− and Blvra G17A mice. Data are expressed as Blvra / Rplp0 (2 −ΔCt ) and presented as individual data points with bar graphs showing mean ± SD. n = 3 mice per genotype. (B) Western blot analysis of BVRA protein expression in spleen, kidney, and liver. Representative blots show BVRA (33 kDa) and β-actin (42 kDa) loading control. Quantification of BVRA protein levels normalized to β-actin is shown below each blot as individual data points with bar graphs showing mean ± SD. n = 3–5 per genotype. (C) RT-qPCR analysis of Blvra mRNA expression in spleen, kidney and liver tissues from Blvra WT , Blvra −/− , and Blvra E97A mice. Data are expressed as Blvra / Rplp0 (2 −ΔCt ) and presented as individual data points with bar graphs showing mean ± SD. n = 3 per genotype. (D) Western blot analysis of BVRA protein expression in spleen, kidney, and liver tissue. Representative blots and quantification of BVRA protein levels normalized to β-actin below each blot, shown as individual data points with bar graphs showing mean ± SD. n = 3–6 mice per genotype. Statistical comparisons were performed using one-way ANOVA with Tukey’s post hoc test. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001; NS, not significant.
Figure Legend Snippet: Expression analysis of BVRA missense mutants G17A and E97A in C57BL/6J mice (A) RT-qPCR analysis of Blvra mRNA expression in spleen, kidney, and liver from Blvra WT , Blvra −/− and Blvra G17A mice. Data are expressed as Blvra / Rplp0 (2 −ΔCt ) and presented as individual data points with bar graphs showing mean ± SD. n = 3 mice per genotype. (B) Western blot analysis of BVRA protein expression in spleen, kidney, and liver. Representative blots show BVRA (33 kDa) and β-actin (42 kDa) loading control. Quantification of BVRA protein levels normalized to β-actin is shown below each blot as individual data points with bar graphs showing mean ± SD. n = 3–5 per genotype. (C) RT-qPCR analysis of Blvra mRNA expression in spleen, kidney and liver tissues from Blvra WT , Blvra −/− , and Blvra E97A mice. Data are expressed as Blvra / Rplp0 (2 −ΔCt ) and presented as individual data points with bar graphs showing mean ± SD. n = 3 per genotype. (D) Western blot analysis of BVRA protein expression in spleen, kidney, and liver tissue. Representative blots and quantification of BVRA protein levels normalized to β-actin below each blot, shown as individual data points with bar graphs showing mean ± SD. n = 3–6 mice per genotype. Statistical comparisons were performed using one-way ANOVA with Tukey’s post hoc test. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001; NS, not significant.

Techniques Used: Expressing, Quantitative RT-PCR, Western Blot, Control

BVRA oxidoreductase activity is dispensable for heme-induced NRF2 activation and insulin receptor signaling in BMDM (A) BMDM from Blvra WT , Blvra −/− , Blvra G17A , and Blvra E97A mice were stimulated with heme and NRF2 activation assessed by immunofluorescence. (B) Representative immunofluorescence images of NRF2 nuclear translocation in BMDM following heme stimulation. Images show confocal z stack cross-sections with orthogonal views. NRF2 is shown in red, DAPI nuclear stain in blue, and phalloidin (cytoskeleton marker) in white. Scale bars, 5 μm. (C) Quantification of cytoplasmic (left graph) or nuclear (right graph) NRF2 MFI in BMDM stimulated with (+) or without (−) heme. Each data point represents a technical replicate. n = 5–10 replicates. Data in (C) is representative from two independent experiments with a similar trend. (D) BMDM from Blvra WT , Blvra −/− , Blvra G17A , and Blvra E97A mice were stimulated with heme and NRF2-regulated gene expression assessed by qRT-PCR. (E) RT-qPCR analysis of NRF2 target genes ( Nqo1 , Fth , Gclc , Hmox1 , Nrf2 , and Blvra ) in BMDM stimulated with (+) or without (−) heme. Data expressed as gene/ Rplp0 (2 −ΔCt ). Each data point represents a technical replicate. n = 3–6 replicates from two independent experiments with a similar trend. (F) BMDM from Blvra WT , Blvra −/− , Blvra G17A , and Blvra E97A mice were stimulated with insulin and INSR signaling assessed by western blot. (G) Representative western blots showing IRS-1 phosphorylation at tyrosine 612 (IRS-1 Y612 ), at serine 307 (IRS-1 S307 ), total IRS-1, and vinculin as loading control in BMDM stimulated with insulin vs. control vehicle. (H) Quantification of IRS-1 Y612 normalized to IRS-1 S307 in BMDM stimulated with (+) or without (−) insulin. Each data point represents a technical replicate. n = 3 replicates from one experiment. Data in (C, E, and H) are presented as individual data points with bar graphs showing mean ± SD. Statistical comparisons were performed using two-way ANOVA with Šídák’s post hoc test. ∗ p < 0.05, ∗∗ p < 0.01; NS, not significant.
Figure Legend Snippet: BVRA oxidoreductase activity is dispensable for heme-induced NRF2 activation and insulin receptor signaling in BMDM (A) BMDM from Blvra WT , Blvra −/− , Blvra G17A , and Blvra E97A mice were stimulated with heme and NRF2 activation assessed by immunofluorescence. (B) Representative immunofluorescence images of NRF2 nuclear translocation in BMDM following heme stimulation. Images show confocal z stack cross-sections with orthogonal views. NRF2 is shown in red, DAPI nuclear stain in blue, and phalloidin (cytoskeleton marker) in white. Scale bars, 5 μm. (C) Quantification of cytoplasmic (left graph) or nuclear (right graph) NRF2 MFI in BMDM stimulated with (+) or without (−) heme. Each data point represents a technical replicate. n = 5–10 replicates. Data in (C) is representative from two independent experiments with a similar trend. (D) BMDM from Blvra WT , Blvra −/− , Blvra G17A , and Blvra E97A mice were stimulated with heme and NRF2-regulated gene expression assessed by qRT-PCR. (E) RT-qPCR analysis of NRF2 target genes ( Nqo1 , Fth , Gclc , Hmox1 , Nrf2 , and Blvra ) in BMDM stimulated with (+) or without (−) heme. Data expressed as gene/ Rplp0 (2 −ΔCt ). Each data point represents a technical replicate. n = 3–6 replicates from two independent experiments with a similar trend. (F) BMDM from Blvra WT , Blvra −/− , Blvra G17A , and Blvra E97A mice were stimulated with insulin and INSR signaling assessed by western blot. (G) Representative western blots showing IRS-1 phosphorylation at tyrosine 612 (IRS-1 Y612 ), at serine 307 (IRS-1 S307 ), total IRS-1, and vinculin as loading control in BMDM stimulated with insulin vs. control vehicle. (H) Quantification of IRS-1 Y612 normalized to IRS-1 S307 in BMDM stimulated with (+) or without (−) insulin. Each data point represents a technical replicate. n = 3 replicates from one experiment. Data in (C, E, and H) are presented as individual data points with bar graphs showing mean ± SD. Statistical comparisons were performed using two-way ANOVA with Šídák’s post hoc test. ∗ p < 0.05, ∗∗ p < 0.01; NS, not significant.

Techniques Used: Activity Assay, Activation Assay, Immunofluorescence, Translocation Assay, Staining, Marker, Gene Expression, Quantitative RT-PCR, Western Blot, Phospho-proteomics, Control

Related Articles

Expressing:

Article Title: Hypomorphic biliverdin reductase a mutations define bilirubin anti-malarial threshold
Article Snippet: C57BL/6J Nrf2 −/− , Jackson Laboratory , Cat#017009; RRID: IMSR_JAX:017009.

Quantitative RT-PCR:

Article Title: Hypomorphic biliverdin reductase a mutations define bilirubin anti-malarial threshold
Article Snippet: C57BL/6J Nrf2 −/− , Jackson Laboratory , Cat#017009; RRID: IMSR_JAX:017009.

Western Blot:

Article Title: Hypomorphic biliverdin reductase a mutations define bilirubin anti-malarial threshold
Article Snippet: C57BL/6J Nrf2 −/− , Jackson Laboratory , Cat#017009; RRID: IMSR_JAX:017009.

Control:

Article Title: Hypomorphic biliverdin reductase a mutations define bilirubin anti-malarial threshold
Article Snippet: C57BL/6J Nrf2 −/− , Jackson Laboratory , Cat#017009; RRID: IMSR_JAX:017009.

Activity Assay:

Article Title: Hypomorphic biliverdin reductase a mutations define bilirubin anti-malarial threshold
Article Snippet: C57BL/6J Nrf2 −/− , Jackson Laboratory , Cat#017009; RRID: IMSR_JAX:017009.

Activation Assay:

Article Title: Hypomorphic biliverdin reductase a mutations define bilirubin anti-malarial threshold
Article Snippet: C57BL/6J Nrf2 −/− , Jackson Laboratory , Cat#017009; RRID: IMSR_JAX:017009.

Immunofluorescence:

Article Title: Hypomorphic biliverdin reductase a mutations define bilirubin anti-malarial threshold
Article Snippet: C57BL/6J Nrf2 −/− , Jackson Laboratory , Cat#017009; RRID: IMSR_JAX:017009.

Translocation Assay:

Article Title: Hypomorphic biliverdin reductase a mutations define bilirubin anti-malarial threshold
Article Snippet: C57BL/6J Nrf2 −/− , Jackson Laboratory , Cat#017009; RRID: IMSR_JAX:017009.

Staining:

Article Title: Hypomorphic biliverdin reductase a mutations define bilirubin anti-malarial threshold
Article Snippet: C57BL/6J Nrf2 −/− , Jackson Laboratory , Cat#017009; RRID: IMSR_JAX:017009.

Marker:

Article Title: Hypomorphic biliverdin reductase a mutations define bilirubin anti-malarial threshold
Article Snippet: C57BL/6J Nrf2 −/− , Jackson Laboratory , Cat#017009; RRID: IMSR_JAX:017009.

Gene Expression:

Article Title: Hypomorphic biliverdin reductase a mutations define bilirubin anti-malarial threshold
Article Snippet: C57BL/6J Nrf2 −/− , Jackson Laboratory , Cat#017009; RRID: IMSR_JAX:017009.

Phospho-proteomics:

Article Title: Hypomorphic biliverdin reductase a mutations define bilirubin anti-malarial threshold
Article Snippet: C57BL/6J Nrf2 −/− , Jackson Laboratory , Cat#017009; RRID: IMSR_JAX:017009.



Similar Products

97
MedChemExpress resveratrol
Validation of the expression of SREBP-1 and <t>Nrf2</t> pathway-related proteins using inhibitors and activators. (A) Western blot analysis of nuclear mature SREBP-1, ACC and FAS in fatostatin-treated OA-induced HepG2 cells. (B) Semi-quantitative results of nuclear mature SREBP-1, ACC and FAS. (C) Western blot analysis of nuclear mature SREBP-1, ACC and FAS in LXR-623-treated OA-induced HepG2 cells. (D) Semi-quantitative results of nuclear mature SREBP-1, ACC and FAS. (E) Western blot analysis of nuclear Nrf2 and HO-1 in ML385-treated OA-induced HepG2 cells. (F) Semi-quantitative results of nuclear Nrf2 and HO-1. (G) Western blot analysis of nuclear Nrf2 and HO-1 in <t>resveratrol-treated</t> OA-induced HepG2 cells. (H) Semi-quantitative results of nuclear Nrf2 and HO-1. Histone H3 and β-actin were used as loading controls for nuclear and total protein, respectively. Compared with the Con group, # p < 0.05, ## p < 0.01; compared with the OA model group, * p < 0.05, ** p < 0.01.
Resveratrol, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nrf2/Nrf2/pmc13770642-59-12-18
Average 97 stars, based on 1 article reviews
resveratrol - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

96
Proteintech nrf2
Effect of GAA on the levels of <t>NRF2,</t> SLC7A11 and GPX4 of AD cells. (A–D) Western blot analysis of NRF2, SLC7A11 and GPX4. (E, F) Immunofluorescence results of NRF2. (G, H) Immunofluorescence results of SLC7A11. (I, J) Immunofluorescence results of GPX4. ** p < 0.01, *** p < 0.001, **** p < 0.0001 ( n = 3 in dependent experiments).
Nrf2, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nrf2/NRF2%2C+NFE2L2+Antibody/pmc13774833-47-54-59
Average 96 stars, based on 1 article reviews
nrf2 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

97
ABclonal Biotechnology anti nrf2
Effect of GAA on the levels of <t>NRF2,</t> SLC7A11 and GPX4 of AD cells. (A–D) Western blot analysis of NRF2, SLC7A11 and GPX4. (E, F) Immunofluorescence results of NRF2. (G, H) Immunofluorescence results of SLC7A11. (I, J) Immunofluorescence results of GPX4. ** p < 0.01, *** p < 0.001, **** p < 0.0001 ( n = 3 in dependent experiments).
Anti Nrf2, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nrf2/NRF2+Rabbit+pAb/pmc13771411-46-0-16
Average 97 stars, based on 1 article reviews
anti nrf2 - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

99
MedChemExpress nrf2 inhibitor ml385
Effect of GAA on the levels of <t>NRF2,</t> SLC7A11 and GPX4 of AD cells. (A–D) Western blot analysis of NRF2, SLC7A11 and GPX4. (E, F) Immunofluorescence results of NRF2. (G, H) Immunofluorescence results of SLC7A11. (I, J) Immunofluorescence results of GPX4. ** p < 0.01, *** p < 0.001, **** p < 0.0001 ( n = 3 in dependent experiments).
Nrf2 Inhibitor Ml385, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nrf2/ML385/pmc13771411-47-1-7
Average 99 stars, based on 1 article reviews
nrf2 inhibitor ml385 - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

98
Cell Signaling Technology Inc anti nrf2
Effect of GAA on the levels of <t>NRF2,</t> SLC7A11 and GPX4 of AD cells. (A–D) Western blot analysis of NRF2, SLC7A11 and GPX4. (E, F) Immunofluorescence results of NRF2. (G, H) Immunofluorescence results of SLC7A11. (I, J) Immunofluorescence results of GPX4. ** p < 0.01, *** p < 0.001, **** p < 0.0001 ( n = 3 in dependent experiments).
Anti Nrf2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nrf2/NRF2+XP+Rabbit+mAb/pmc13773482-399-36-37
Average 98 stars, based on 1 article reviews
anti nrf2 - by Bioz Stars, 2026-11
98/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology nrf 2
Effect of GAA on the levels of <t>NRF2,</t> SLC7A11 and GPX4 of AD cells. (A–D) Western blot analysis of NRF2, SLC7A11 and GPX4. (E, F) Immunofluorescence results of NRF2. (G, H) Immunofluorescence results of SLC7A11. (I, J) Immunofluorescence results of GPX4. ** p < 0.01, *** p < 0.001, **** p < 0.0001 ( n = 3 in dependent experiments).
Nrf 2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nrf2/Nrf2+Antibody/pmc13764283-183-46-49
Average 96 stars, based on 1 article reviews
nrf 2 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Proteintech nrf2 rabbit pab
Effect of GAA on the levels of <t>NRF2,</t> SLC7A11 and GPX4 of AD cells. (A–D) Western blot analysis of NRF2, SLC7A11 and GPX4. (E, F) Immunofluorescence results of NRF2. (G, H) Immunofluorescence results of SLC7A11. (I, J) Immunofluorescence results of GPX4. ** p < 0.01, *** p < 0.001, **** p < 0.0001 ( n = 3 in dependent experiments).
Nrf2 Rabbit Pab, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nrf2/NRF2%2C+NFE2L2+Antibody/pm42998702-54-35-42
Average 96 stars, based on 1 article reviews
nrf2 rabbit pab - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology mouse anti nrf2
Effect of GAA on the levels of <t>NRF2,</t> SLC7A11 and GPX4 of AD cells. (A–D) Western blot analysis of NRF2, SLC7A11 and GPX4. (E, F) Immunofluorescence results of NRF2. (G, H) Immunofluorescence results of SLC7A11. (I, J) Immunofluorescence results of GPX4. ** p < 0.01, *** p < 0.001, **** p < 0.0001 ( n = 3 in dependent experiments).
Mouse Anti Nrf2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nrf2/Nrf2+Antibody/10__3390_slash_antiox15111440-91-28-50
Average 96 stars, based on 1 article reviews
mouse anti nrf2 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

Image Search Results


Validation of the expression of SREBP-1 and Nrf2 pathway-related proteins using inhibitors and activators. (A) Western blot analysis of nuclear mature SREBP-1, ACC and FAS in fatostatin-treated OA-induced HepG2 cells. (B) Semi-quantitative results of nuclear mature SREBP-1, ACC and FAS. (C) Western blot analysis of nuclear mature SREBP-1, ACC and FAS in LXR-623-treated OA-induced HepG2 cells. (D) Semi-quantitative results of nuclear mature SREBP-1, ACC and FAS. (E) Western blot analysis of nuclear Nrf2 and HO-1 in ML385-treated OA-induced HepG2 cells. (F) Semi-quantitative results of nuclear Nrf2 and HO-1. (G) Western blot analysis of nuclear Nrf2 and HO-1 in resveratrol-treated OA-induced HepG2 cells. (H) Semi-quantitative results of nuclear Nrf2 and HO-1. Histone H3 and β-actin were used as loading controls for nuclear and total protein, respectively. Compared with the Con group, # p < 0.05, ## p < 0.01; compared with the OA model group, * p < 0.05, ** p < 0.01.

Journal: Food Chemistry: X

Article Title: A novel polysaccharide extracted from sea buckthorn pomace: purification, structural properties, and lipid-lowering potential

doi: 10.1016/j.fochx.2026.104769

Figure Lengend Snippet: Validation of the expression of SREBP-1 and Nrf2 pathway-related proteins using inhibitors and activators. (A) Western blot analysis of nuclear mature SREBP-1, ACC and FAS in fatostatin-treated OA-induced HepG2 cells. (B) Semi-quantitative results of nuclear mature SREBP-1, ACC and FAS. (C) Western blot analysis of nuclear mature SREBP-1, ACC and FAS in LXR-623-treated OA-induced HepG2 cells. (D) Semi-quantitative results of nuclear mature SREBP-1, ACC and FAS. (E) Western blot analysis of nuclear Nrf2 and HO-1 in ML385-treated OA-induced HepG2 cells. (F) Semi-quantitative results of nuclear Nrf2 and HO-1. (G) Western blot analysis of nuclear Nrf2 and HO-1 in resveratrol-treated OA-induced HepG2 cells. (H) Semi-quantitative results of nuclear Nrf2 and HO-1. Histone H3 and β-actin were used as loading controls for nuclear and total protein, respectively. Compared with the Con group, # p < 0.05, ## p < 0.01; compared with the OA model group, * p < 0.05, ** p < 0.01.

Article Snippet: Fatostatin hydrobromide (SREBP-1 inhibitor), LXR-623 (SREBP-1 indirect activator), ML385 (Nrf2 inhibitor), and resveratrol (Nrf2 activator) were purchased from MedChemExpress (Shanghai, China).

Techniques: Biomarker Discovery, Expressing, Western Blot, Analysis

Effect of GAA on the levels of NRF2, SLC7A11 and GPX4 of AD cells. (A–D) Western blot analysis of NRF2, SLC7A11 and GPX4. (E, F) Immunofluorescence results of NRF2. (G, H) Immunofluorescence results of SLC7A11. (I, J) Immunofluorescence results of GPX4. ** p < 0.01, *** p < 0.001, **** p < 0.0001 ( n = 3 in dependent experiments).

Journal: Food Science & Nutrition

Article Title: Ganoderic Acid A Ameliorates Recognition Memory Deficits and Anxiety‐ and Depression‐Like Behaviors in APP / PS1 Mice: Association With Histone Lactylation and Ferroptosis

doi: 10.1002/fsn3.72603

Figure Lengend Snippet: Effect of GAA on the levels of NRF2, SLC7A11 and GPX4 of AD cells. (A–D) Western blot analysis of NRF2, SLC7A11 and GPX4. (E, F) Immunofluorescence results of NRF2. (G, H) Immunofluorescence results of SLC7A11. (I, J) Immunofluorescence results of GPX4. ** p < 0.01, *** p < 0.001, **** p < 0.0001 ( n = 3 in dependent experiments).

Article Snippet: GAA (> 98% purity, Lot No. LB486701) from Yuanye (Shanghai, China); DMEM from VivaCell (Shanghai, China); Aβ 25‐35 , 2‐DG, and LA from Sigma‐Aldrich (St. Louis, MO, USA); ECL solution and BCA kit from Biosharp (Hefei, China); CCK‐8 kit and primary antibodies against Pan‐Kla, H4K12la, H4K8la, H3K18la, H3K9la, LDH, p300, HDAC1, TFR1, FTH1, ACSL4, NRF2, SLC7A11, and GPX4 from Proteintech (Rosemont, IL, USA); anti‐β‐actin from Abbkine (Wuhan, China); iron assay kit from Mlbio (Shanghai, China); and all other assay kits (for L‐lactic acid, LDH, p300, HDAC1, T‐AOC, SOD, MDA, GSSG, GSH, ROS), IF blocking solution, Cy3‐labeled goat anti‐rabbit IgG (H + L), and Alexa Fluor 488‐conjugated goat anti‐rabbit IgG (H + L) from Beyotime (Shanghai, China).

Techniques: Western Blot, Analysis, Immunofluorescence